产品名称 | NebuSelect™ Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E, His-tag |
---|---|
目录号 | NBL-241567 |
别名 | Envelope glycoprotein E |
外观 | see COA |
分子量 | Ser31-Tyr538 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9J3M8 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241567-100ug | 100ug | Inquire | Inquire | |
NBL-241567-1mg | 1mg | Inquire | Inquire | |
NBL-241567-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E, His-tag
Catalog#:
NBL-241567
Description:
NebuSelect™ Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E, His-tag(Cat#NBL-241567) is expressed in HEK293 with His tag at the C-Terminus.; It contains Ser31-Tyr538.
Species:
Varicella-zostervirus(strainOkavaccine)
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 58.39 kDa. Due to glycosylation, the protein migrates to 65-85 kDa based on Bis-Tris PAGE result.
Target Name:
Envelope glycoprotein E
Target Information:
VZV glycoprotein E (gE) is most abundantly expressed on the surface of infected cells, and is an essential component for virus replication and cell-to-cell transmission. It is also the main target of virus-specific antibodies and T cell responses that is often selected as vaccine candidate antigen.
Amino Acid Sequence:
Ser31-Tyr538
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.